Clinical trial tracker

Clinical trial tracker

Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.

Reset

3 registered trials, newest registry update first. Showing only trials linked to AOD-9604.

TrialCompoundPhaseStatusSponsorEnrolledPrimary completionRegistry updated
A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain
NCT05298306
AOD-9604Phase 1CompletedLateral Pharma Pty Ltd26May 12, 2023Nov 27, 2024
Oral LAT8881 in Neuropathic Pain
NCT03865953
AOD-9604Phase 2CompletedLateral Pharma Pty Ltd53Apr 19, 2020Jun 14, 2021
A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine
NCT04153409
AOD-9604Phase 2CompletedLateral Pharma Pty Ltd21Feb 15, 2020Apr 28, 2021

Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.